Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?

Sepideh Mirzaei,Ali Zarrabi,Farid Hashemi,Amirhossein Zabolian,Hossein Saleki,Adnan Ranjbar,Seyed Hesam Seyed Saleh,Morteza Bagherian,Kiavash Hushmandi,Alena Liskova,Peter Kubatka,Pooyan Makvandi,Vinay Tergaonkar,Alan Prem Kumar,Milad Ashrafizadeh,Gautam Sethi,Seyed omid Sharifzadeh

DOI: https://doi.org/10.1016/j.canlet.2021.03.025

IF: 9.756

2021-07-01

Cancer Letters

Abstract:The nuclear factor-kappaB (NF-κB) signaling pathway is considered as a potential therapeutic target in cancer therapy. It has been well established that transcription factor NF-κB is involved in regulating physiological and pathological events including inflammation, immune response and differentiation. Increasing evidences suggest that deregulated NF-κB signaling can enhance cancer cell proliferation, metastasis and also mediate radio-as well as chemo-resistance. On the contrary, non-coding RNAs (ncRNAs) have been found to modulate NF-κB signaling pathway under different settings. MicroRNAs (miRNAs) can dually inhibit/induce NF-κB signaling thereby affecting the growth and migration of cancer cells. Furthermore, the response of cancer cells to radiotherapy and chemotherapy may also be regulated by miRNAs. Regulation of NF-κB by miRNAs may be mediated via binding to 3/-UTR region. Interestingly, anti-tumor compounds can increase the expression of tumor-suppressor miRNAs in inhibiting NF-κB activation and the progression of cancers. Long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) can also effectively modulate NF-κB signaling thus affecting tumorigenesis. Noteworthy, several studies demonstrate that lncRNAs and circRNAs can affect miRNAs in targeting NF-κB activate. They can act as competing endogenous RNA (ceRNA) thereby reducing miRNA expression to induce NF-κB activation that can enhance cancer progression and malignancy.

oncology